{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T06:12:01Z","timestamp":1794550321835,"version":"4.9.1"},"reference-count":131,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"UZH Candoc Grant"},{"DOI":"10.13039\/100000874","name":"Brain and Behavior Research Foundation","doi-asserted-by":"publisher","award":["30963"],"award-info":[{"award-number":["30963"]}],"id":[{"id":"10.13039\/100000874","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008475","name":"Hartmann-M\u00fcller Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008475","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["310030_188524"],"award-info":[{"award-number":["310030_188524"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["320030-231937"],"award-info":[{"award-number":["320030-231937"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol."],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Prenatal exposure to infectious or non-infectious maternal immune activation (MIA) represents a transdiagnostic environmental risk factor for psychiatric and neurodevelopmental disorders. Building on previous findings of locomotor hyperactivity in a subset of male MIA offspring, the present study investigated whether viral-like MIA in mice recapitulates features of attention-deficit\/hyperactivity disorder (ADHD) in this subgroup. We show that 40\u201350% of MIA-exposed male offspring develop locomotor hyperactivity in a novel environment, which is most pronounced during early- to mid-adolescence and precedes the emergence of increased impulsive behavior and pre-attentive filtering deficits in early adulthood. We further identified subgroup-specific dopaminergic and noradrenergic alterations in cortical and subcortical brain regions of MIA offspring. These neuronal alterations were age-dependent and correlated with behavioral changes. Moreover, treatment with methylphenidate (MPH), a first-line pharmacological therapy for ADHD, normalized locomotor hyperactivity and restored abnormal mesolimbic and striatal activation patterns in susceptible MIA offspring. Collectively, our findings demonstrate that MIA in mice recapitulates key features of ADHD in a susceptible subset of offspring, supporting the notion that MIA may contribute etiologically to ADHD in some individuals. More broadly, our results suggest that the heterogeneous neurobehavioral outcomes of MIA offspring may result from distinct yet overlapping pathophysiological mechanisms across neurodevelopmental and psychiatric disorders.<\/jats:p>","DOI":"10.1038\/s41386-026-02373-7","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T10:54:50Z","timestamp":1772276090000},"page":"1497-1510","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Maternal immune activation in mice recapitulates features of attention-deficit\/hyperactivity disorder (ADHD) in susceptible offspring"],"prefix":"10.1038","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-6669-139X","authenticated-orcid":false,"given":"Ron","family":"Schaer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Wenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Notter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7244-0345","authenticated-orcid":false,"given":"Urs","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,28]]},"reference":[{"key":"2373_CR1","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1176\/appi.ajp.2018.17121311","volume":"175","author":"AS Brown","year":"2018","unstructured":"Brown AS, Meyer U. Maternal immune activation and neuropsychiatric illness: a translational research perspective. Am J Psychiatry. 2018;175:1073\u201383.","journal-title":"Am J Psychiatry"},{"key":"2373_CR2","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.tins.2019.08.001","volume":"42","author":"U Meyer","year":"2019","unstructured":"Meyer U. Neurodevelopmental resilience and susceptibility to maternal immune activation. Trends Neurosci. 2019;42:793\u2013806.","journal-title":"Trends Neurosci"},{"key":"2373_CR3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.biopsych.2018.08.008","volume":"85","author":"SB Gumusoglu","year":"2019","unstructured":"Gumusoglu SB, Stevens HE. Maternal inflammation and neurodevelopmental programming: a review of preclinical outcomes and implications for translational psychiatry. Biol Psychiatry. 2019;85:107\u201321.","journal-title":"Biol Psychiatry"},{"key":"2373_CR4","doi-asserted-by":"publisher","unstructured":"Vasistha NA, Sawa A. Prenatal immune stress: its impact on brain development and neuropsychiatric disorders. Annu Rev Neurosci. 2025;2025. https:\/\/doi.org\/10.1146\/annurev-neuro-112723-024048.","DOI":"10.1146\/annurev-neuro-112723-024048"},{"key":"2373_CR5","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/mp.2016.77","volume":"22","author":"KL Jones","year":"2017","unstructured":"Jones KL, Croen LA, Yoshida CK, Heuer L, Hansen R, Zerbo O, et al. Autism with intellectual disability is associated with increased levels of maternal cytokines and chemokines during gestation. Mol Psychiatry. 2017;22:273\u20139.","journal-title":"Mol Psychiatry"},{"key":"2373_CR6","doi-asserted-by":"publisher","first-page":"e00159","DOI":"10.1128\/mSphere.00159-17","volume":"2","author":"M Mahic","year":"2017","unstructured":"Mahic M, Che X, Susser E, Levin B, Reichborn-Kjennerud T, Magnus P, et al. Epidemiological and serological investigation into the role of gestational maternal influenza virus infection and autism spectrum disorders. mSphere. 2017;2:e00159\u201317.","journal-title":"mSphere"},{"key":"2373_CR7","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/mp.2017.119","volume":"23","author":"M Hornig","year":"2018","unstructured":"Hornig M, Bresnahan MA, Che X, Schultz AF, Ukaigwe JE, Eddy ML, et al. Prenatal fever and autism risk. Mol Psychiatry. 2018;23:759\u201366.","journal-title":"Mol Psychiatry"},{"key":"2373_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-61918-2","volume":"14","author":"V Fajardo-Martinez","year":"2024","unstructured":"Fajardo-Martinez V, Ferreira F, Fuller T, Cambou MC, Kerin T, Paiola S, et al. Neurodevelopmental delay in children exposed to maternal SARS-CoV-2 in-utero. Sci Rep. 2024;14:11851.","journal-title":"Sci Rep"},{"key":"2373_CR9","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41380-020-00952-8","volume":"26","author":"FS Mueller","year":"2021","unstructured":"Mueller FS, Scarborough J, Schalbetter SM, Richetto J, Kim E, Couch A, et al. Behavioral, neuroanatomical, and molecular correlates of resilience and susceptibility to maternal immune activation. Mol Psychiatry. 2021;26:396\u2013410.","journal-title":"Mol Psychiatry"},{"key":"2373_CR10","first-page":"100514","volume":"25","author":"JM Lorusso","year":"2022","unstructured":"Lorusso JM, Woods RM, McEwan F, Glazier JD, Neill JC, Harte M, et al. Clustering of cognitive phenotypes identifies susceptible and resilient offspring in a rat model of maternal immune activation and early-life stress. Brain Behav Immun. 2022;25:100514.","journal-title":"Brain Behav Immun"},{"key":"2373_CR11","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.bbi.2022.10.006","volume":"107","author":"F Herrero","year":"2023","unstructured":"Herrero F, Mueller FS, Gruchot J, K\u00fcry P, Weber-Stadlbauer U, Meyer U. Susceptibility and resilience to maternal immune activation are associated with differential expression of endogenous retroviral elements. Brain Behav Immun. 2023;107:201\u201314.","journal-title":"Brain Behav Immun"},{"key":"2373_CR12","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.bbi.2024.06.015","volume":"120","author":"R Schaer","year":"2024","unstructured":"Schaer R, Mueller FS, Notter T, Weber-Stadlbauer U, Meyer U. Intrauterine position effects in a mouse model of maternal immune activation. Brain Behav Immun. 2024;120:391\u2013402.","journal-title":"Brain Behav Immun"},{"key":"2373_CR13","first-page":"119","volume":"28","author":"U Weber-Stadlbauer","year":"2019","unstructured":"Weber-Stadlbauer U, Meyer U. Challenges and opportunities of a-priori and a-posteriori variability in maternal immune activation models. Curr Opin. Behav Sci. 2019;28:119\u201328.","journal-title":"Behav Sci"},{"key":"2373_CR14","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.bbi.2025.06.040","volume":"129","author":"R Schaer","year":"2025","unstructured":"Schaer R, Wenger N, Herrero F, Notter T, Meyer U. Ontogeny and plasticity of resilience and susceptibility in a mouse model of maternal immune activation. Brain Behav Immun. 2025;129:666\u201380.","journal-title":"Brain Behav Immun"},{"key":"2373_CR15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1017\/S0033291705006410","volume":"36","author":"J Biederman","year":"2006","unstructured":"Biederman J, Monuteaux MC, Mick E, Spencer T, Wilens TE, Silva JM, et al. Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up study. Psychol Med. 2006;36:167\u201379.","journal-title":"Psychol Med"},{"key":"2373_CR16","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.euroneuro.2018.08.001","volume":"28","author":"B Franke","year":"2018","unstructured":"Franke B, Michelini G, Asherson P, Banaschewski T, Bilbow A, Buitelaar JK, et al. Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan. Eur Neuropsychopharmacol. 2018;28:1059\u201388.","journal-title":"Eur Neuropsychopharmacol"},{"key":"2373_CR17","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.neubiorev.2021.01.022","volume":"128","author":"SV Faraone","year":"2021","unstructured":"Faraone SV, Banaschewski T, Coghill D, Zheng Y, Biederman J, Bellgrove MA, et al. The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder. Neurosci Biobehav Rev. 2021;128:789\u2013818.","journal-title":"Neurosci Biobehav Rev"},{"key":"2373_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41572-024-00495-0","volume":"10","author":"SV Faraone","year":"2024","unstructured":"Faraone SV, Bellgrove MA, Brikell I, Cortese S, Hartman CA, Hollis C, et al. Attention-deficit\/hyperactivity disorder. Nat Rev Dis Primer. 2024;10:11.","journal-title":"Nat Rev Dis Primer"},{"key":"2373_CR19","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1176\/ajp.2006.163.4.716","volume":"163","author":"RC Kessler","year":"2006","unstructured":"Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006;163:716\u201323.","journal-title":"Am J Psychiatry"},{"key":"2373_CR20","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1586\/14737175.2016.1146591","volume":"16","author":"KM Antshel","year":"2016","unstructured":"Antshel KM, Zhang-James Y, Wagner KE, Ledesma A, Faraone SV. An update on the comorbidity of ADHD and ASD: a focus on clinical management. Expert Rev Neurother. 2016;16:279\u201393.","journal-title":"Expert Rev Neurother"},{"key":"2373_CR21","doi-asserted-by":"publisher","first-page":"101759","DOI":"10.1016\/j.rasd.2021.101759","volume":"83","author":"Y Rong","year":"2021","unstructured":"Rong Y, Yang C-J, Jin Y, Wang Y. Prevalence of attention-deficit\/hyperactivity disorder in individuals with autism spectrum disorder: a meta-analysis. Res Autism Spectr Disord. 2021;83:101759.","journal-title":"Res Autism Spectr Disord"},{"key":"2373_CR22","doi-asserted-by":"publisher","first-page":"e090290","DOI":"10.1136\/bmjopen-2024-090290","volume":"14","author":"J Bamford","year":"2024","unstructured":"Bamford J, Qurashi I, Axiaq A, Marwaha S, Husain N. Comorbid ADHD and schizophrenia and the use of psychostimulants: a scoping review protocol. BMJ Open. 2024;14:e090290.","journal-title":"BMJ Open"},{"key":"2373_CR23","doi-asserted-by":"crossref","unstructured":"Cheng N, Bryce S, Takagi M, Pert A, Rattray A, Fisher E, et al. The prevalence of attention deficit hyperactivity disorder in psychotic disorders: systematic review and meta-analysis. Schizophr Bull. 2025; 51:1514\u201328.","DOI":"10.1093\/schbul\/sbae228"},{"key":"2373_CR24","doi-asserted-by":"publisher","first-page":"4859","DOI":"10.1038\/s41380-025-03080-3","volume":"30","author":"JJ Luykx","year":"2025","unstructured":"Luykx JJ, Corbeil O, K\u00e4rkk\u00e4inen O, Tanskanen A, Mittendorfer-Rutz E, Tiihonen J, et al. Long term safety of ADHD medication in patients with schizophrenia spectrum disorders. Mol Psychiatry. 2025;30:4859\u201367.","journal-title":"Mol Psychiatry"},{"key":"2373_CR25","doi-asserted-by":"publisher","first-page":"e12233","DOI":"10.1371\/journal.pone.0012233","volume":"5","author":"C Cheung","year":"2010","unstructured":"Cheung C, Yu K, Fung G, Leung M, Wong C, Li Q, et al. Autistic disorders and schizophrenia: related or remote? An anatomical likelihood estimation. PloS One. 2010;5:e12233.","journal-title":"PloS One"},{"key":"2373_CR26","doi-asserted-by":"publisher","first-page":"26R","DOI":"10.1203\/PDR.0b013e318212c196","volume":"69","author":"U Meyer","year":"2011","unstructured":"Meyer U, Feldon J, Dammann O. Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation? Pediatr Res. 2011;69:26R\u201333R.","journal-title":"Pediatr Res"},{"key":"2373_CR27","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/S1474-4422(13)70011-5","volume":"12","author":"A Moreno-De-Luca","year":"2013","unstructured":"Moreno-De-Luca A, Myers SM, Challman TD, Moreno-De-Luca D, Evans DW, Ledbetter DH. Developmental brain dysfunction: revival and expansion of old concepts based on new genetic evidence. Lancet Neurol. 2013;12:406\u201314.","journal-title":"Lancet Neurol"},{"key":"2373_CR28","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1176\/appi.focus.17103","volume":"17","author":"MJ Gandal","year":"2019","unstructured":"Gandal MJ, Haney JR, Parikshak NN, Leppa V, Ramaswami G, Hartl C, et al. Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap. Focus. 2019;17:66\u201372.","journal-title":"Focus"},{"key":"2373_CR29","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/wps.20440","volume":"16","author":"MJ Owen","year":"2017","unstructured":"Owen MJ, O\u2019Donovan MC. Schizophrenia and the neurodevelopmental continuum:evidence from genomics. World Psychiatry. 2017;16:227\u201335.","journal-title":"World Psychiatry"},{"key":"2373_CR30","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.biopsych.2015.11.024","volume":"81","author":"JT Instanes","year":"2017","unstructured":"Instanes JT, Halm\u00f8y A, Engeland A, Haavik J, Furu K, Klungs\u00f8yr K. Attention-deficit\/hyperactivity disorder in offspring of mothers with inflammatory and immune system diseases. Biol Psychiatry. 2017;81:452\u20139.","journal-title":"Biol Psychiatry"},{"key":"2373_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-45920-7","volume":"9","author":"K Gustavson","year":"2019","unstructured":"Gustavson K, Ask H, Ystrom E, Stoltenberg C, Lipkin WI, Sur\u00e9n P, et al. Maternal fever during pregnancy and offspring attention deficit hyperactivity disorder. Sci Rep. 2019;9:9519.","journal-title":"Sci Rep"},{"key":"2373_CR32","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.bbi.2019.05.040","volume":"80","author":"WJ Cowell","year":"2019","unstructured":"Cowell WJ, Bellinger DC, Wright RO, Wright RJ. Antenatal active maternal asthma and other atopic disorders is associated with ADHD behaviors among school-aged children. Brain Behav Immun. 2019;80:871\u20138.","journal-title":"Brain Behav Immun"},{"key":"2373_CR33","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/ppe.13022","volume":"38","author":"TC Nielsen","year":"2024","unstructured":"Nielsen TC, Nassar N, Shand AW, Jones HF, Han VX, Patel S, et al. Association between cumulative maternal exposures related to inflammation and child attention-deficit\/hyperactivity disorder: a cohort study. Paediatr Perinat Epidemiol. 2024;38:241\u201350.","journal-title":"Paediatr Perinat Epidemiol"},{"key":"2373_CR34","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.bbi.2024.09.009","volume":"123","author":"N Borbye-Lorenzen","year":"2025","unstructured":"Borbye-Lorenzen N, Holmgaard S, Ottosson F, Nudel R, Appadurai V, Laursen TM, et al. High level of immunoglobulin G targeting mycoplasma or cytomegalovirus in the newborn increases risk of ADHD. Brain Behav Immun. 2025;123:99\u2013107.","journal-title":"Brain Behav Immun"},{"key":"2373_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-025-04227-3","volume":"23","author":"KM Walle","year":"2025","unstructured":"Walle KM, Gustavson K, Mjaaland S, Askeland RB, Magnus P, Susser E, et al. Maternal immune-mediated conditions and ADHD risk in offspring. BMC Med. 2025;23:348.","journal-title":"BMC Med"},{"key":"2373_CR36","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1001\/jamapsychiatry.2025.0122","volume":"82","author":"T Wang","year":"2025","unstructured":"Wang T, Mohammadzadeh P, Jepsen JRM, Thorsen J, Rosenberg JB, Koldb\u00e6k Lemvigh C, et al. Maternal inflammatory proteins in pregnancy and neurodevelopmental disorders at age 10 years. JAMA Psychiatry. 2025;82:514\u201325.","journal-title":"JAMA Psychiatry"},{"key":"2373_CR37","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/jcpp.12959","volume":"60","author":"Y Ginsberg","year":"2019","unstructured":"Ginsberg Y, D\u2019Onofrio BM, Rickert ME, Class QA, Rosenqvist MA, Almqvist C, et al. Maternal infection requiring hospitalization during pregnancy and attention-deficit hyperactivity disorder in offspring: a quasi-experimental family-based study. J Child Psychol Psychiatry. 2019;60:160\u20138.","journal-title":"J Child Psychol Psychiatry"},{"key":"2373_CR38","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00787-019-01372-y","volume":"29","author":"R Chudal","year":"2020","unstructured":"Chudal R, Brown AS, Gyllenberg D, Hinkka-Yli-Salom\u00e4ki S, Sucksdorff M, Surcel H-M, et al. Maternal serum C-reactive protein (CRP) and offspring attention deficit hyperactivity disorder (ADHD). Eur Child Adolesc Psychiatry. 2020;29:239\u201347.","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"2373_CR39","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1007\/s00787-020-01580-x","volume":"30","author":"J Jallow","year":"2021","unstructured":"Jallow J, Halt A-H, \u00d6hman H, Hurtig T. Prenatal inflammation does not increase the risk for symptoms of attention deficit hyperactivity disorder (ADHD) in offspring. Eur Child Adolesc Psychiatry. 2021;30:1825\u20138.","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"2373_CR40","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1007\/s00787-023-02276-8","volume":"33","author":"P Ellul","year":"2024","unstructured":"Ellul P, Wallez S, Acquaviva E, Rosenzwajg M, Klatzmann D, Delorme R, et al. Children with a history of both maternal immune activation and prematurity are not at increased risk of ADHD symptoms. Eur Child Adolesc Psychiatry. 2024;33:2001\u20134.","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"2373_CR41","doi-asserted-by":"publisher","first-page":"104757","DOI":"10.1016\/j.neubiorev.2022.104757","volume":"139","author":"M Kanarik","year":"2022","unstructured":"Kanarik M, Grimm O, Mota NR, Reif A, Harro J. ADHD co-morbidities: A review of implication of gene \u00d7 environment effects with dopamine-related genes. Neurosci Biobehav Rev. 2022;139:104757.","journal-title":"Neurosci Biobehav Rev"},{"key":"2373_CR42","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1177\/108705470200500302","volume":"5","author":"J Gershon","year":"2002","unstructured":"Gershon J. A meta-analytic review of gender differences in ADHD. J Atten Disord. 2002;5:143\u201354.","journal-title":"J Atten Disord"},{"key":"2373_CR43","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.biopsych.2006.04.042","volume":"61","author":"A Scheres","year":"2007","unstructured":"Scheres A, Milham MP, Knutson B, Castellanos FX. Ventral striatal hyporesponsiveness during reward anticipation in attention-deficit\/hyperactivity disorder. Biol Psychiatry. 2007;61:720\u20134.","journal-title":"Biol Psychiatry"},{"key":"2373_CR44","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.biopsych.2009.10.033","volume":"67","author":"A Scheres","year":"2010","unstructured":"Scheres A, Tontsch C, Thoeny AL, Kaczkurkin A. Temporal reward discounting in attention-deficit\/hyperactivity disorder: the contribution of symptom domains, reward magnitude, and session length. Biol Psychiatry. 2010;67:641\u20138.","journal-title":"Biol Psychiatry"},{"key":"2373_CR45","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/mp.2010.97","volume":"16","author":"ND Volkow","year":"2011","unstructured":"Volkow ND, Wang G-J, Newcorn JH, Kollins SH, Wigal TL, Telang F, et al. Motivation deficit in ADHD is associated with dysfunction of the dopamine reward pathway. Mol Psychiatry. 2011;16:1147\u201354.","journal-title":"Mol Psychiatry"},{"key":"2373_CR46","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.neuroimage.2011.12.011","volume":"60","author":"G Wilbertz","year":"2012","unstructured":"Wilbertz G, van Elst LT, Delgado MR, Maier S, Feige B, Philipsen A, et al. Orbitofrontal reward sensitivity and impulsivity in adult attention deficit hyperactivity disorder. NeuroImage. 2012;60:353\u201361.","journal-title":"NeuroImage"},{"key":"2373_CR47","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1177\/1087054711427398","volume":"16","author":"R Hasson","year":"2012","unstructured":"Hasson R, Fine JG. Gender differences among children with ADHD on continuous performance tests: a meta-analytic review. J Atten Disord. 2012;16:190\u20138.","journal-title":"J Atten Disord"},{"key":"2373_CR48","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.cpr.2015.11.001","volume":"43","author":"CHG Patros","year":"2016","unstructured":"Patros CHG, Alderson RM, Kasper LJ, Tarle SJ, Lea SE, Hudec KL. Choice-impulsivity in children and adolescents with attention-deficit\/hyperactivity disorder (ADHD): A meta-analytic review. Clin Psychol Rev. 2016;43:162\u201374.","journal-title":"Clin Psychol Rev"},{"key":"2373_CR49","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1177\/1087054718772138","volume":"25","author":"I Marx","year":"2021","unstructured":"Marx I, Hacker T, Yu X, Cortese S, Sonuga-Barke E. ADHD and the choice of small immediate over larger delayed rewards: a comparative meta-analysis of performance on simple choice-delay and temporal discounting paradigms. J Atten Disord. 2021;25:171\u201387.","journal-title":"J Atten Disord"},{"key":"2373_CR50","first-page":"607","volume":"27","author":"A Kirley","year":"2002","unstructured":"Kirley A, Hawi Z, Daly G, McCarron M, Mullins C, Millar N, et al. Dopaminergic system genes in ADHD: toward a biological hypothesis. Neuropsychopharmacology. 2002;27:607\u201319.","journal-title":"Neuropsychopharmacology"},{"key":"2373_CR51","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.biopsych.2005.03.036","volume":"57","author":"TJ Spencer","year":"2005","unstructured":"Spencer TJ, Biederman J, Madras BK, Faraone SV, Dougherty DD, Bonab AA, et al. In vivo neuroreceptor imaging in attention-deficit\/hyperactivity disorder: a focus on the dopamine transporter. Biol Psychiatry. 2005;57:1293\u20131300.","journal-title":"Biol Psychiatry"},{"key":"2373_CR52","doi-asserted-by":"publisher","first-page":"e145","DOI":"10.1016\/j.biopsych.2011.02.036","volume":"69","author":"N Del Campo","year":"2011","unstructured":"Del Campo N, Chamberlain SR, Sahakian BJ, Robbins TW. The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit\/hyperactivity disorder. Biol Psychiatry. 2011;69:e145\u2013157.","journal-title":"Biol Psychiatry"},{"key":"2373_CR53","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1001\/jamapsychiatry.2014.1226","volume":"71","author":"T Vanicek","year":"2014","unstructured":"Vanicek T, Spies M, Rami-Mark C, Savli M, H\u00f6flich A, Kranz GS, et al. The norepinephrine transporter in attention-deficit\/hyperactivity disorder investigated with positron emission tomography. JAMA Psychiatry. 2014;71:1340\u20139.","journal-title":"JAMA Psychiatry"},{"key":"2373_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-019-0619-y","volume":"9","author":"C Ulke","year":"2019","unstructured":"Ulke C, Rullmann M, Huang J, Luthardt J, Becker G-A, Patt M, et al. Adult attention-deficit\/hyperactivity disorder is associated with reduced norepinephrine transporter availability in right attention networks: a (S,S)-O-[11C]methylreboxetine positron emission tomography study. Transl Psychiatry. 2019;9:301.","journal-title":"Transl Psychiatry"},{"key":"2373_CR55","doi-asserted-by":"publisher","first-page":"1492126","DOI":"10.3389\/fpsyt.2024.1492126","volume":"15","author":"HJ MacDonald","year":"2024","unstructured":"MacDonald HJ, Kleppe R, Szigetvari PD, Haavik J. The dopamine hypothesis for ADHD: An evaluation of evidence accumulated from human studies and animal models. Front Psychiatry. 2024;15:1492126.","journal-title":"Front Psychiatry"},{"key":"2373_CR56","doi-asserted-by":"publisher","first-page":"36","DOI":"10.21037\/tp.2017.08.02","volume":"7","author":"KA Brown","year":"2018","unstructured":"Brown KA, Samuel S, Patel DR. Pharmacologic management of attention deficit hyperactivity disorder in children and adolescents: a review for practitioners. Transl Pediatr. 2018;7:36\u201347.","journal-title":"Transl Pediatr"},{"key":"2373_CR57","doi-asserted-by":"publisher","first-page":"107940","DOI":"10.1016\/j.pharmthera.2021.107940","volume":"230","author":"K Mechler","year":"2022","unstructured":"Mechler K, Banaschewski T, Hohmann S, H\u00e4ge A. Evidence-based pharmacological treatment options for ADHD in children and adolescents. Pharmacol Ther. 2022;230:107940.","journal-title":"Pharmacol Ther"},{"key":"2373_CR58","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.bbi.2018.07.014","volume":"73","author":"FS Mueller","year":"2018","unstructured":"Mueller FS, Polesel M, Richetto J, Meyer U, Weber-Stadlbauer U. Mouse models of maternal immune activation: mind your caging system!. Brain Behav Immun. 2018;73:643\u201360.","journal-title":"Brain Behav Immun"},{"key":"2373_CR59","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.bbi.2019.04.019","volume":"80","author":"FS Mueller","year":"2019","unstructured":"Mueller FS, Richetto J, Hayes LN, Zambon A, Pollak DD, Sawa A, et al. Influence of poly(I:C) variability on thermoregulation, immune responses and pregnancy outcomes in mouse models of maternal immune activation. Brain Behav Immun. 2019;80:406\u201318.","journal-title":"Brain Behav Immun"},{"key":"2373_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-024-03014-7","volume":"14","author":"KE Tillmann","year":"2024","unstructured":"Tillmann KE, Schaer R, Mueller FS, Mueller K, Voelkl B, Weber-Stadlbauer U, et al. Differential effects of purified low molecular weight Poly(I:C) in the maternal immune activation model depend on the laboratory environment. Transl Psychiatry. 2024;14:300.","journal-title":"Transl Psychiatry"},{"key":"2373_CR61","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41386-018-0185-7","volume":"44","author":"AC Kentner","year":"2019","unstructured":"Kentner AC, Bilbo SD, Brown AS, Hsiao EY, McAllister AK, Meyer U, et al. Maternal immune activation: reporting guidelines to improve the rigor, reproducibility, and transparency of the model. Neuropsychopharmacology. 2019;44:245\u201358.","journal-title":"Neuropsychopharmacology"},{"key":"2373_CR62","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0166-4328(01)00291-1","volume":"125","author":"C Belzung","year":"2001","unstructured":"Belzung C, Griebel G. Measuring normal and pathological anxiety-like behaviour in mice: a review. Behav Brain Res. 2001;125:141\u20139.","journal-title":"Behav Brain Res"},{"key":"2373_CR63","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.bbi.2020.04.015","volume":"88","author":"J Scarborough","year":"2020","unstructured":"Scarborough J, Mueller F, Arban R, Dorner-Ciossek C, Weber-Stadlbauer U, Rosenbrock H, et al. Preclinical validation of the micropipette-guided drug administration (MDA) method in the maternal immune activation model of neurodevelopmental disorders. Brain Behav Immun. 2020;88:461\u201370.","journal-title":"Brain Behav Immun"},{"key":"2373_CR64","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41684-021-00723-0","volume":"50","author":"SM Schalbetter","year":"2021","unstructured":"Schalbetter SM, Mueller FS, Scarborough J, Richetto J, Weber-Stadlbauer U, Meyer U, et al. Oral application of clozapine-N-oxide using the micropipette-guided drug administration (MDA) method in mouse DREADD systems. Lab Anim. 2021;50:69\u201375.","journal-title":"Lab Anim"},{"key":"2373_CR65","doi-asserted-by":"publisher","first-page":"114967","DOI":"10.1016\/j.physbeh.2025.114967","volume":"299","author":"O Krzyzaniak","year":"2025","unstructured":"Krzyzaniak O, Steiner S, Nilsson FAM, Dietrich M, K\u00e4mpfen L, Johansen P, et al. Applicability of the micropipette-guided drug administration (MDA) method for assessing reward-related behaviors in mice. Physiol Behav. 2025;299:114967.","journal-title":"Physiol Behav"},{"key":"2373_CR66","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.biopsych.2014.03.011","volume":"78","author":"A-M Zimmermann","year":"2015","unstructured":"Zimmermann A-M, Jene T, Wolf M, G\u00f6rlich A, Gurniak CB, Sasso\u00e8-Pognetto M, et al. Attention-deficit\/hyperactivity disorder-like phenotype in a mouse model with impaired actin dynamics. Biol Psychiatry. 2015;78:95\u2013106.","journal-title":"Biol Psychiatry"},{"key":"2373_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-33778-0","volume":"8","author":"O Bouchatta","year":"2018","unstructured":"Bouchatta O, Manouze H, Bouali-Benazzouz R, Kerekes N, Ba-M\u2019hamed S, Fossat P, et al. Neonatal 6-OHDA lesion model in mouse induces Attention-Deficit\/ Hyperactivity Disorder (ADHD)-like behaviour. Sci Rep. 2018;8:15349.","journal-title":"Sci Rep"},{"key":"2373_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-021-00749-y","volume":"14","author":"T Hori","year":"2021","unstructured":"Hori T, Ikuta S, Hattori S, Takao K, Miyakawa T, Koike C. Mice with mutations in Trpm1, a gene in the locus of 15q13.3 microdeletion syndrome, display pronounced hyperactivity and decreased anxiety-like behavior. Mol Brain. 2021;14:61.","journal-title":"Mol Brain"},{"key":"2373_CR69","doi-asserted-by":"publisher","first-page":"112620","DOI":"10.1016\/j.bbr.2020.112620","volume":"388","author":"A Kiryk","year":"2020","unstructured":"Kiryk A, Janusz A, Zglinicki B, Turkes E, Knapska E, Konopka W, et al. IntelliCage as a tool for measuring mouse behavior - 20 years perspective. Behav Brain Res. 2020;388:112620.","journal-title":"Behav Brain Res"},{"key":"2373_CR70","doi-asserted-by":"publisher","first-page":"683780","DOI":"10.3389\/fnbeh.2021.683780","volume":"15","author":"IN Iman","year":"2021","unstructured":"Iman IN, Yusof NAM, Talib UN, Ahmad NAZ, Norazit A, Kumar J, et al. The IntelliCage System: a review of its utility as a novel behavioral platform for a rodent model of substance use disorder. Front Behav Neurosci. 2021;15:683780.","journal-title":"Front Behav Neurosci"},{"key":"2373_CR71","doi-asserted-by":"publisher","first-page":"1270159","DOI":"10.3389\/fnbeh.2024.1270159","volume":"18","author":"M Nigri","year":"2024","unstructured":"Nigri M, Bramati G, Steiner AC, Wolfer DP. Appetitively motivated tasks in the IntelliCage reveal a higher motivational cost of spatial learning in male than female mice. Front Behav Neurosci. 2024;18:1270159.","journal-title":"Front Behav Neurosci"},{"key":"2373_CR72","doi-asserted-by":"publisher","first-page":"1270538","DOI":"10.3389\/fnbeh.2023.1270538","volume":"17","author":"H-P Lipp","year":"2024","unstructured":"Lipp H-P, Krackow S, Turkes E, Benner S, Endo T, Russig H. IntelliCage: the development and perspectives of a mouse- and user-friendly automated behavioral test system. Front Behav Neurosci. 2024;17:1270538.","journal-title":"Front Behav Neurosci"},{"key":"2373_CR73","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.euroneuro.2023.08.496","volume":"77","author":"MJ Primo","year":"2023","unstructured":"Primo MJ, Fonseca-Rodrigues D, Almeida A, Teixeira PM, Pinto-Ribeiro F. Sucrose preference test: a systematic review of protocols for the assessment of anhedonia in rodents. Eur Neuropsychopharmacology. 2023;77:80\u201392.","journal-title":"Eur Neuropsychopharmacology"},{"key":"2373_CR74","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/S0959-4388(96)80077-8","volume":"6","author":"TW Robbins","year":"1996","unstructured":"Robbins TW, Everitt BJ. Neurobehavioural mechanisms of reward and motivation. Curr Opin Neurobiol. 1996;6:228\u201336.","journal-title":"Curr Opin Neurobiol"},{"key":"2373_CR75","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s00213-021-05760-8","volume":"238","author":"CC Wrenn","year":"2021","unstructured":"Wrenn CC, French E, Baker D, McCallian R, Kirk R, Reilly MP, et al. Effects of clonidine on progressive ratio schedule performance in Fmr1 knockout mice. Psychopharmacology. 2021;238:1133\u201340.","journal-title":"Psychopharmacology"},{"key":"2373_CR76","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1038\/s41386-024-01868-5","volume":"49","author":"J Delaney","year":"2024","unstructured":"Delaney J, Nathani S, Tan V, Chavez C, Orr A, Paek J, et al. Enhanced cognitive flexibility and phasic striatal dopamine dynamics in a mouse model of low striatal tonic dopamine. Neuropsychopharmacology. 2024;49:1600\u20138.","journal-title":"Neuropsychopharmacology"},{"key":"2373_CR77","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1007\/s00213-003-1551-6","volume":"170","author":"AR Isles","year":"2003","unstructured":"Isles AR, Humby T, Wilkinson LS. Measuring impulsivity in mice using a novel operant delayed reinforcement task: effects of behavioural manipulations and d-amphetamine. Psychopharmacology. 2003;170:376\u201382.","journal-title":"Psychopharmacology"},{"key":"2373_CR78","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.bbr.2005.02.034","volume":"162","author":"EB Johansen","year":"2005","unstructured":"Johansen EB, Sagvolden T, Kvande G. Effects of delayed reinforcers on the behavior of an animal model of attention-deficit\/hyperactivity disorder (ADHD). Behav Brain Res. 2005;162:47\u201361.","journal-title":"Behav Brain Res"},{"key":"2373_CR79","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.bbr.2006.09.001","volume":"175","author":"DJ Hand","year":"2006","unstructured":"Hand DJ, Fox AT, Reilly MP. Response acquisition with delayed reinforcement in a rodent model of attention-deficit\/hyperactivity disorder (ADHD). Behav Brain Res. 2006;175:337\u201342.","journal-title":"Behav Brain Res"},{"key":"2373_CR80","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00213-008-1072-4","volume":"199","author":"NR Swerdlow","year":"2008","unstructured":"Swerdlow NR, Weber M, Qu Y, Light GA, Braff DL. Realistic expectations of prepulse inhibition in translational models for schizophrenia research. Psychopharmacology. 2008;199:331\u201388.","journal-title":"Psychopharmacology"},{"key":"2373_CR81","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1038\/s41380-020-0745-1","volume":"26","author":"T Notter","year":"2021","unstructured":"Notter T, Schalbetter SM, Clifton NE, Mattei D, Richetto J, Thomas K, et al. Neuronal activity increases translocator protein (TSPO) levels. Mol Psychiatry. 2021;26:2025\u201337.","journal-title":"Mol Psychiatry"},{"key":"2373_CR82","doi-asserted-by":"publisher","first-page":"eabi6672","DOI":"10.1126\/sciadv.abi6672","volume":"8","author":"SM Schalbetter","year":"2022","unstructured":"Schalbetter SM, von Arx AS, Cruz-Ochoa N, Dawson K, Ivanov A, Mueller FS, et al. Adolescence is a sensitive period for prefrontal microglia to act on cognitive development. Sci Adv. 2022;8:eabi6672.","journal-title":"Sci Adv"},{"key":"2373_CR83","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.biopsych.2004.10.011","volume":"57","author":"BK Madras","year":"2005","unstructured":"Madras BK, Miller GM, Fischman AJ. The dopamine transporter and attention-deficit\/hyperactivity disorder. Biol Psychiatry. 2005;57:1397\u2013409.","journal-title":"Biol Psychiatry"},{"key":"2373_CR84","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.neuroscience.2010.02.073","volume":"167","author":"V Roessner","year":"2010","unstructured":"Roessner V, Sagvolden T, Dasbanerjee T, Middleton FA, Faraone SV, Walaas SI, et al. Methylphenidate normalizes elevated dopamine transporter densities in an animal model of the attention-deficit\/hyperactivity disorder combined type, but not to the same extent in one of the attention-deficit\/hyperactivity disorder inattentive type. Neuroscience. 2010;167:1183\u201391.","journal-title":"Neuroscience"},{"key":"2373_CR85","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.neuropharm.2012.08.020","volume":"63","author":"EM Miller","year":"2012","unstructured":"Miller EM, Pomerleau F, Huettl P, Russell VA, Gerhardt GA, Glaser PEA. The spontaneously hypertensive and Wistar Kyoto rat models of ADHD exhibit sub-regional differences in dopamine release and uptake in the striatum and nucleus accumbens. Neuropharmacology. 2012;63:1327\u201334.","journal-title":"Neuropharmacology"},{"key":"2373_CR86","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jneumeth.2015.02.002","volume":"252","author":"SS Somkuwar","year":"2015","unstructured":"Somkuwar SS, Kantak KM, Dwoskin LP. Effect of methylphenidate treatment during adolescence on norepinephrine transporter function in orbitofrontal cortex in a rat model of attention deficit hyperactivity disorder. J Neurosci Methods. 2015;252:55\u201363.","journal-title":"J Neurosci Methods"},{"key":"2373_CR87","doi-asserted-by":"publisher","first-page":"173378","DOI":"10.1016\/j.pbb.2022.173378","volume":"216","author":"KM Kantak","year":"2022","unstructured":"Kantak KM. Rodent models of attention-deficit hyperactivity disorder: An updated framework for model validation and therapeutic drug discovery. Pharmacol Biochem Behav. 2022;216:173378.","journal-title":"Pharmacol Biochem Behav"},{"key":"2373_CR88","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/j.1471-4159.1977.tb07780.x","volume":"29","author":"NG Bacopoulos","year":"1977","unstructured":"Bacopoulos NG, Bhatnagar RK. Correlation between tyrosine hydroxylase activity and catecholamine concentration or turnover in brain regions. J Neurochem. 1977;29:639\u201343.","journal-title":"J Neurochem"},{"key":"2373_CR89","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0006-8993(79)90755-8","volume":"162","author":"DL Cimarusti","year":"1979","unstructured":"Cimarusti DL, Saito K, Vaughn JE, Barber R, Roberts E, Thomas PE. Immunocytochemical localization of dopamine-beta-hydroxylase in rat locus coeruleus and hypothalamus. Brain Res. 1979;162:55\u201367.","journal-title":"Brain Res"},{"key":"2373_CR90","doi-asserted-by":"publisher","first-page":"852","DOI":"10.3389\/fpsyt.2020.00852","volume":"11","author":"A Aguilar-Valles","year":"2020","unstructured":"Aguilar-Valles A, Rodrigue B, Matta-Camacho E. Maternal immune activation and the development of dopaminergic neurotransmission of the offspring: relevance for schizophrenia and other psychoses. Front Psychiatry. 2020;11:852.","journal-title":"Front Psychiatry"},{"key":"2373_CR91","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/sj.npp.1301413","volume":"33","author":"U Meyer","year":"2008","unstructured":"Meyer U, Nyffeler M, Schwendener S, Knuesel I, Yee BK, Feldon J. Relative prenatal and postnatal maternal contributions to schizophrenia-related neurochemical dysfunction after in utero immune challenge. Neuropsychopharmacology. 2008;33:441\u201356.","journal-title":"Neuropsychopharmacology"},{"key":"2373_CR92","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1523\/JNEUROSCI.5408-09.2010","volume":"30","author":"S Vuillermot","year":"2010","unstructured":"Vuillermot S, Weber L, Feldon J, Meyer U. A longitudinal examination of the neurodevelopmental impact of prenatal immune activation in mice reveals primary defects in dopaminergic development relevant to schizophrenia. J Neurosci. 2010;30:1270\u201387.","journal-title":"J Neurosci"},{"key":"2373_CR93","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/(SICI)1096-9861(20000501)420:2<211::AID-CNE5>3.0.CO;2-3","volume":"420","author":"S Schroeter","year":"2000","unstructured":"Schroeter S, Apparsundaram S, Wiley RG, Miner LH, Sesack SR, Blakely RD. Immunolocalization of the cocaine- and antidepressant-sensitive l-norepinephrine transporter. J Comp Neurol. 2000;420:211\u201332.","journal-title":"J Comp Neurol"},{"key":"2373_CR94","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/cne.10898","volume":"466","author":"LH Miner","year":"2003","unstructured":"Miner LH, Schroeter S, Blakely RD, Sesack SR. Ultrastructural localization of the norepinephrine transporter in superficial and deep layers of the rat prelimbic prefrontal cortex and its spatial relationship to probable dopamine terminals. J Comp Neurol. 2003;466:478\u201394.","journal-title":"J Comp Neurol"},{"key":"2373_CR95","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3389\/fnmol.2019.00334","volume":"12","author":"Y Ranjbar-Slamloo","year":"2019","unstructured":"Ranjbar-Slamloo Y, Fazlali Z. Dopamine and noradrenaline in the brain; overlapping or dissociate functions? Front Mol Neurosci. 2019;12:334.","journal-title":"Front Mol Neurosci"},{"key":"2373_CR96","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1017\/S003329170500471X","volume":"36","author":"SV Faraone","year":"2006","unstructured":"Faraone SV, Biederman J, Mick E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med. 2006;36:159\u201365.","journal-title":"Psychol Med"},{"key":"2373_CR97","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1017\/neu.2021.23","volume":"33","author":"R Di Lorenzo","year":"2021","unstructured":"Di Lorenzo R, Balducci J, Poppi C, Arcolin E, Cutino A, Ferri P, et al. Children and adolescents with ADHD followed up to adulthood: a systematic review of long-term outcomes. Acta Neuropsychiatr. 2021;33:283\u201398.","journal-title":"Acta Neuropsychiatr"},{"key":"2373_CR98","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.neubiorev.2004.10.012","volume":"29","author":"U Meyer","year":"2005","unstructured":"Meyer U, Feldon J, Schedlowski M, Yee BK. Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia. Neurosci Biobehav Rev. 2005;29:913\u201347.","journal-title":"Neurosci Biobehav Rev"},{"key":"2373_CR99","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.bbi.2007.09.012","volume":"22","author":"U Meyer","year":"2008","unstructured":"Meyer U, Nyffeler M, Yee BK, Knuesel I, Feldon J. Adult brain and behavioral pathological markers of prenatal immune challenge during early\/middle and late fetal development in mice. Brain Behav Immun. 2008;22:469\u201386.","journal-title":"Brain Behav Immun"},{"key":"2373_CR100","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.pneurobio.2009.10.018","volume":"90","author":"U Meyer","year":"2010","unstructured":"Meyer U, Feldon J. Epidemiology-driven neurodevelopmental animal models of schizophrenia. Prog Neurobiol. 2010;90:285\u2013326.","journal-title":"Prog Neurobiol"},{"key":"2373_CR101","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s00213-002-1235-7","volume":"165","author":"LW Hawk","year":"2003","unstructured":"Hawk LW, Yartz AR, Pelham WE, Lock TM. The effects of methylphenidate on prepulse inhibition during attended and ignored prestimuli among boys with attention-deficit hyperactivity disorder. Psychopharmacology. 2003;165:118\u201327.","journal-title":"Psychopharmacology"},{"key":"2373_CR102","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.jpsychires.2008.06.004","volume":"43","author":"D Feifel","year":"2009","unstructured":"Feifel D, Minassian A, Perry W. Prepulse inhibition of startle in adults with ADHD. J Psychiatr Res. 2009;43:484\u20139.","journal-title":"J Psychiatr Res"},{"key":"2373_CR103","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1037\/a0019859","volume":"119","author":"A Conzelmann","year":"2010","unstructured":"Conzelmann A, Pauli P, Mucha RF, Jacob CP, Gerdes ABM, Romanos J, et al. Early attentional deficits in an attention-to-prepulse paradigm in ADHD adults. J Abnorm Psychol. 2010;119:594\u2013603.","journal-title":"J Abnorm Psychol"},{"key":"2373_CR104","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.euroneuro.2021.02.004","volume":"46","author":"J Sommer","year":"2021","unstructured":"Sommer J, le, Low A-M, Jepsen JRM, Fagerlund B, Vangkilde S, Habekost T, et al. Effects of methylphenidate on sensory and sensorimotor gating of initially psychostimulant-na\u00efve adult ADHD patients. Eur Neuropsychopharmacology. 2021;46:83\u201392.","journal-title":"Eur Neuropsychopharmacology"},{"key":"2373_CR105","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s002130100810","volume":"156","author":"DL Braff","year":"2001","unstructured":"Braff DL, Geyer MA, Swerdlow NR. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology. 2001;156:234\u201358.","journal-title":"Psychopharmacology"},{"key":"2373_CR106","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.biopsych.2016.08.010","volume":"81","author":"J Richetto","year":"2017","unstructured":"Richetto J, Massart R, Weber-Stadlbauer U, Szyf M, Riva MA, Meyer U. Genome-wide DNA methylation changes in a mouse model of infection-mediated neurodevelopmental disorders. Biol Psychiatry. 2017;81:265\u201376.","journal-title":"Biol Psychiatry"},{"key":"2373_CR107","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1093\/schbul\/sbs195","volume":"40","author":"J Richetto","year":"2014","unstructured":"Richetto J, Calabrese F, Riva MA, Meyer U. Prenatal immune activation induces maturation-dependent alterations in the prefrontal GABAergic transcriptome. Schizophr Bull. 2014;40:351\u201361.","journal-title":"Schizophr Bull"},{"key":"2373_CR108","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0166-4328(90)90091-R","volume":"37","author":"M Bubser","year":"1990","unstructured":"Bubser M, Schmidt WJ. 6-Hydroxydopamine lesion of the rat prefrontal cortex increases locomotor activity, impairs acquisition of delayed alternation tasks, but does not affect uninterrupted tasks in the radial maze. Behav Brain Res. 1990;37:157\u201368.","journal-title":"Behav Brain Res"},{"key":"2373_CR109","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.pneurobio.2013.06.005","volume":"108","author":"A Bari","year":"2013","unstructured":"Bari A, Robbins TW. Inhibition and impulsivity: behavioral and neural basis of response control. Prog Neurobiol. 2013;108:44\u201379.","journal-title":"Prog Neurobiol"},{"key":"2373_CR110","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.neuropharm.2015.05.032","volume":"97","author":"AM Novick","year":"2015","unstructured":"Novick AM, Forster GL, Hassell JE, Davies DR, Scholl JL, Renner KJ, et al. Increased dopamine transporter function as a mechanism for dopamine hypoactivity in the adult infralimbic medial prefrontal cortex following adolescent social stress. Neuropharmacology. 2015;97:194\u2013200.","journal-title":"Neuropharmacology"},{"key":"2373_CR111","doi-asserted-by":"publisher","first-page":"113199","DOI":"10.1016\/j.bbr.2021.113199","volume":"405","author":"M Moreno","year":"2021","unstructured":"Moreno M, Azocar V, Verg\u00e9s A, Fuentealba JA. High impulsive choice is accompanied by an increase in dopamine release in rat dorsolateral striatum. Behav Brain Res. 2021;405:113199.","journal-title":"Behav Brain Res"},{"key":"2373_CR112","doi-asserted-by":"publisher","first-page":"5901","DOI":"10.1523\/JNEUROSCI.18-15-05901.1998","volume":"18","author":"M Ernst","year":"1998","unstructured":"Ernst M, Zametkin AJ, Matochik JA, Jons PH, Cohen RM. DOPA decarboxylase activity in attention deficit hyperactivity disorder adults. A [fluorine-18]fluorodopa positron emission tomographic study. J Soc Neurosci. 1998;18:5901\u20137.","journal-title":"J Soc Neurosci"},{"key":"2373_CR113","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1007\/s002590000330","volume":"27","author":"S Dresel","year":"2000","unstructured":"Dresel S, Krause J, Krause KH, LaFougere C, Brinkb\u00e4umer K, Kung HF, et al. Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment. Eur J Nucl Med. 2000;27:1518\u201324.","journal-title":"Eur J Nucl Med"},{"key":"2373_CR114","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/j.neuroimage.2006.10.014","volume":"34","author":"ND Volkow","year":"2007","unstructured":"Volkow ND, Wang G-J, Newcorn J, Fowler JS, Telang F, Solanto MV, et al. Brain dopamine transporter levels in treatment and drug na\u00efve adults with ADHD. NeuroImage. 2007;34:1182\u201390.","journal-title":"NeuroImage"},{"key":"2373_CR115","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1176\/appi.ajp.2011.11060940","volume":"169","author":"P Fusar-Poli","year":"2012","unstructured":"Fusar-Poli P, Rubia K, Rossi G, Sartori G, Balottin U. Striatal dopamine transporter alterations in ADHD: pathophysiology or adaptation to psychostimulants? A meta-analysis. Am J Psychiatry. 2012;169:264\u201372.","journal-title":"Am J Psychiatry"},{"key":"2373_CR116","doi-asserted-by":"publisher","first-page":"e63023","DOI":"10.1371\/journal.pone.0063023","volume":"8","author":"G-J Wang","year":"2013","unstructured":"Wang G-J, Volkow ND, Wigal T, Kollins SH, Newcorn JH, Telang F, et al. Long-term stimulant treatment affects brain dopamine transporter level in patients with attention deficit hyperactive disorder. PLoS ONE. 2013;8:e63023.","journal-title":"PLoS ONE"},{"key":"2373_CR117","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.biopsych.2005.02.002","volume":"57","author":"T Sagvolden","year":"2005","unstructured":"Sagvolden T, Russell VA, Aase H, Johansen EB, Farshbaf M. Rodent models of attention-deficit\/hyperactivity disorder. Biol Psychiatry. 2005;57:1239\u201347.","journal-title":"Biol Psychiatry"},{"key":"2373_CR118","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jneumeth.2006.12.005","volume":"161","author":"VA Russell","year":"2007","unstructured":"Russell VA. Neurobiology of animal models of attention-deficit hyperactivity disorder. J Neurosci Methods. 2007;161:185\u201398.","journal-title":"J Neurosci Methods"},{"key":"2373_CR119","doi-asserted-by":"publisher","first-page":"e170434","DOI":"10.1172\/jci.insight.170434","volume":"8","author":"D Liu","year":"2023","unstructured":"Liu D, Xie Z, Gu P, Li X, Zhang Y, Wang X, et al. Cry1\u039411 mutation induces ADHD-like symptoms through hyperactive dopamine D1 receptor signaling. JCI Insight. 2023;8:e170434.","journal-title":"JCI Insight"},{"key":"2373_CR120","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.neuropharm.2012.04.031","volume":"63","author":"Y Ohno","year":"2012","unstructured":"Ohno Y, Okano M, Masui A, Imaki J, Egawa M, Yoshihara C, et al. Region-specific elevation of D\u2081 receptor-mediated neurotransmission in the nucleus accumbens of SHR, a rat model of attention deficit\/hyperactivity disorder. Neuropharmacology. 2012;63:547\u201354.","journal-title":"Neuropharmacology"},{"key":"2373_CR121","doi-asserted-by":"publisher","first-page":"104857","DOI":"10.1016\/j.neuint.2020.104857","volume":"141","author":"T Jogamoto","year":"2020","unstructured":"Jogamoto T, Utsunomiya R, Sato A, Kihara N, Choudhury ME, Miyanishi K, et al. Lister hooded rats as a novel animal model of attention-deficit\/hyperactivity disorder. Neurochem Int. 2020;141:104857.","journal-title":"Neurochem Int"},{"key":"2373_CR122","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s11064-017-2439-x","volume":"43","author":"T Monfil","year":"2018","unstructured":"Monfil T, V\u00e1zquez Roque RA, Camacho-Abrego I, Tendilla-Beltran H, Iannitti T, Meneses-Morales I, et al. Hyper-response to novelty increases c-Fos expression in the hippocampus and prefrontal cortex in a rat model of schizophrenia. Neurochem Res. 2018;43:441\u20138.","journal-title":"Neurochem Res"},{"key":"2373_CR123","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1093\/brain\/awy048","volume":"141","author":"A Sethi","year":"2018","unstructured":"Sethi A, Voon V, Critchley HD, Cercignani M, Harrison NA. A neurocomputational account of reward and novelty processing and effects of psychostimulants in attention deficit hyperactivity disorder. Brain J Neurol. 2018;141:1545\u201357.","journal-title":"Brain J Neurol"},{"key":"2373_CR124","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.pbb.2011.01.020","volume":"99","author":"AFT Arnsten","year":"2011","unstructured":"Arnsten AFT, Pliszka SR. Catecholamine influences on prefrontal cortical function: relevance to treatment of attention deficit\/hyperactivity disorder and related disorders. Pharmacol Biochem Behav. 2011;99:211\u20136.","journal-title":"Pharmacol Biochem Behav"},{"key":"2373_CR125","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.bbi.2005.11.003","volume":"20","author":"U Meyer","year":"2006","unstructured":"Meyer U, Feldon J, Schedlowski M, Yee BK. Immunological stress at the maternal-foetal interface: a link between neurodevelopment and adult psychopathology. Brain Behav Immun. 2006;20:378\u201388.","journal-title":"Brain Behav Immun"},{"key":"2373_CR126","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/mp.2015.222","volume":"21","author":"S Canetta","year":"2016","unstructured":"Canetta S, Bolkan S, Padilla-Coreano N, Song LJ, Sahn R, Harrison NL, et al. Maternal immune activation leads to selective functional deficits in offspring parvalbumin interneurons. Mol Psychiatry. 2016;21:956\u201368.","journal-title":"Mol Psychiatry"},{"key":"2373_CR127","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1037\/bne0000540","volume":"137","author":"AR Deane","year":"2023","unstructured":"Deane AR, Jing Y, Shoorangiz R, Liu P, Ward RD. Cognitive and arginine metabolic correlates of temporal dysfunction in the MIA rat model of schizophrenia risk. Behav Neurosci. 2023;137:67\u201377.","journal-title":"Behav Neurosci"},{"key":"2373_CR128","doi-asserted-by":"publisher","first-page":"e0299380","DOI":"10.1371\/journal.pone.0299380","volume":"19","author":"M Maroon","year":"2024","unstructured":"Maroon M, Haddad F, Doornaert E, Allman B, Schmid S. Investigating gene-environment interaction on attention in a double-hit model for Autism Spectrum Disorder. PLoS ONE. 2024;19:e0299380.","journal-title":"PLoS ONE"},{"key":"2373_CR129","first-page":"101075","volume":"48","author":"JA Hubbard","year":"2025","unstructured":"Hubbard JA, Chen S, Iosif AM, Ryan AM, Murai T, Hogrefe CE, et al. Maternal immune activation alters infant attentional processing in a nonhuman primate model. Brain Behav Immun. 2025;48:101075.","journal-title":"Brain Behav Immun"},{"key":"2373_CR130","doi-asserted-by":"publisher","first-page":"106134","DOI":"10.1016\/j.bbi.2025.106134","volume":"131","author":"M Zarchev","year":"2025","unstructured":"Zarchev M, Gigase FAJ, de Witte L, Cecil CAM, Hillegers MHJ, Ospina LH, et al. Maternal infection - but not inflammation - is associated with attention-deficit\/hyperactivity disorder symptoms during childhood: a population-based cohort study. Brain Behav Immun. 2025;131:106134.","journal-title":"Brain Behav Immun"},{"key":"2373_CR131","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41380-018-0070-0","volume":"24","author":"SV Faraone","year":"2019","unstructured":"Faraone SV, Larsson H. Genetics of attention deficit hyperactivity disorder. Mol Psychiatry. 2019;24:562\u201375.","journal-title":"Mol Psychiatry"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41386-026-02373-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-026-02373-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-026-02373-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T09:24:27Z","timestamp":1782206667000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-026-02373-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,28]]},"references-count":131,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["2373"],"URL":"https:\/\/doi.org\/10.1038\/s41386-026-02373-7","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,28]]},"assertion":[{"value":"14 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}